Lyon, Jul 13, 2023 – THERANEXUS raises around 3.1 million euros in fundraising DOWNLOAD THERANEXUS press release
Lyon, Jan 13, 2022 – THERANEXUS publishes its cash position as of 31 december 2021. Implementation of a new equity line. DOWNLOAD THERANEXUS press release
Lyon, 18 January 2021 – Theranexus, a biopharmaceutical company innovating in the treatment of neurologicaldiseases and pioneer in the development of drug candidates modulating the interaction between neurons and glialcells, presents an update on its activities and announces the strengthening of its financial visibilityfor the medium term.